Propanc Health Group Corporation is listing on the Over The Counter Bulletin Board.
For more information, please refer to our Prospectus.
Key Features:
- Global demand for effective, safe and easy to administer cancer treatments is increasing rapidly;
- Propanc seeks worldwide regulatory approval in several therapeutic indications targeting tumor types where a medical need is established and few treatment options exist;
- 15 years scientific research and clinical experience from treating patients in the UK & Australia has provided evidence that PRP may be an effective treatment against cancer and warrants further development
- Propanc is building an IP portfolio around our scientific understanding of the effects of proenzymes in cancer, identifying new formulations, new routes of administration and potential new therapeutic targets
